All posts tagged mdt

Medtronic Neuromodulation Business Gets FDA Warning Letter

Medtronic Inc.’s (MDT) business for neuromodulation devices recently received a Food and Drug Administration warning letter related mainly to the company’s processes for handling complaints, the medical-device maker disclosed Tuesday. “We are working with the FDA to quickly resolve the …

Continue Reading...

Medtronic Granted CE Mark

Medtronic has been rewarded with a CE Mark for a new non-surgical procedure it has devised that is suitable for young children suffering from life-threatening curvature of the

DOJ

Medtronic receives notification that U.S. Department Of Justice and U.S. Attorney’s office have closed their investigation of activities relating to Infuse® bone graft

MINNEAPOLIS – MAY 16, 2012 – Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the United States Attorney for the

Med-tech trends: Styker, Medtronic, Covidien, St. Jude, Boston Scientific the most talked about device makers in April

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
 

Click to enlarge.

 
MassDevice.com looked at some

Medtronic to Ramp-Up Device Inspections

Medtronic, Inc., the world's largest stand-alone medical device maker, is no longer going to rely on irregular reports from doctors or patients to monitor its medical devices. Instead

Medtronic Announces Launch of the POWEREASE(TM) System

MEMPHIS, Tenn., Apr 16, 2012 (BUSINESS WIRE) -- Medtronic, Inc. MDT -0.05% today announced the initiation of its launch of the POWEREASE(TM) System, an innovative system of electronic instruments

More shareholders sue Medtronic over Infuse claims

Medtronic (NYSE:MDT) found itself at the center of another shareholder lawsuit accusing it of artificially boosting its stock price and forcing the company

Medtronic

Medical device tax to cost Medtronic about $125M to $175M annually

It appears that Medtronic (NYSE: MDT) is assuming that all the efforts to repeal the medical device taxare not going to amount to much and that companies will have

Could Black Bear Blood Replace Infuse?

Black bear blood sounds like a bizarre source for a bone growth enhancer. However, Aursos, Inc. a Michigan-based company, is counting on a biomarker in the blood of

downsizing word cloud box package

Medtronic indicates it’s considering selling its spine unit

Posted:   02/21/2012 12:01:00 AM CST
Updated:   02/21/2012 09:36:39 PM CST
Another quarter of weak sales in Medtronic's division for spine devices stirred talk

Medtronic debuts new spinal fusion procedure

Medtronic Inc.    has introduced a new spinal surgery product which the company says improves on current methods of spinal fusion surgery. The product, called MAST MIDLF, uses smaller incisions

Medtronic: Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Medtronic Inc. (MDT). Below are some highlights from the above linked analysis:
Company Description: Medtronic Inc.is a global

Courtroom

JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT

JURY FINDS NUVASIVE INFRINGES 3 
MEDTRONIC PATENTS, AWARDS 
MEDTRONIC $101.2M IN DAMAGES; 
MAINTAIN HOLD AND $22.50 PT

Click Here for the Entire Article From Canaccord

medtronic

NuVasive Announces Jury Verdict in Patent Case

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that a jury in the U.S.

Jury Awards Medtronic $101 Million In Patent Suit Against NuVasive

MEMPHIS, TENN. – Sept. 20, 2011 – Medtronic, Inc. (NYSE: MDT) announced today that a jury in the United States District Court of the Southern District of California in San